Heart Disease News and Research

Latest Heart Disease News and Research

LehmanMillet honored with four prestigious industry awards

HealthSTAR's LehmanMillet, the leading agency devoted to working with health care companies changing standards of care, today announced it has won four prestigious industry awards: an MM&M (Medical Marketing & Media Magazine) Gold Award for work done on behalf of Abbott Nutrition; a First Place DxMA (Diagnostic Marketing Association) award for work done on behalf of Abbott Diagnostics; a First Place DxMA Award for work done on behalf of BRAHMS USA; and a PM360 Pharma Choice Bronze Award.

9 Jan 2010

Svelte Medical Systems initiates European clinical trial for SOAW delivery system

Svelte Medical Systems, Inc. is pleased to announce that it has initiated its European clinical trial at the Thoraxcenter Research Center in Rotterdam, the Netherlands for its “Stent-on-a-Wire” (SOAW) cobalt–chromium Bare Metal Stent.

9 Jan 2010

Boston Scientific's PROMUS Everolimus-Eluting Coronary Stent System receives Japanese marketing approval

Boston Scientific Corporation announced today that it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its PROMUS® Everolimus-Eluting Coronary Stent System for the treatment of coronary artery disease. The Company plans to launch the product as soon as reimbursement approval is granted, which is expected in the coming weeks.

9 Jan 2010

FDA grants unconditional approval for World Heart's Levacor VAD BTT study

World Heart Corporation, a developer of mechanical circulatory systems, announced today that it has received unconditional approval from the U.S. Food and Drug Administration ("FDA") for the bridge-to-transplant ("BTT") study of the Levacor Ventricular Assist Device ("VAD"). Study enrollment will encompass 160 subjects, a reduction from the approximately 200 subjects of the original statistical plan. As previously announced, the BTT study will begin initially at ten clinical sites.

8 Jan 2010

Health Canada clears Zargis Cardioscan device for sale in Canada

Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp. (Nasdaq: SPDE), today announced that Health Canada, the Canadian equivalent of the U.S. FDA, has cleared the Zargis Cardioscan(TM) device for sale in Canada.

8 Jan 2010

VA expected to move soon to cover more effects of Agent Orange

The Department of Veterans Affairs may need to pay heavily to treat veterans who have been adversely affected by Agent Orange. McClatchy/Beaufort (S.C.) Gazette report: "The cost of war -- on veterans' health and taxpayer wallets -- will loom a little larger in the new year when the Department of Veterans Affairs issues a final rule to claim adjudicators to presume three more diseases of Vietnam veterans, including heart disease, were caused by exposure to Agent Orange.

8 Jan 2010

Possible loopholes, insurance costs in Senate health bill

"A critical loophole in the current version of the Senate health-care bill would allow insurers to charge more for those who don't participate in wellness programs, essentially negating the measure's key goal of eliminating higher costs for those with pre-existing conditions, a group of health experts said Thursday," MarketWatch reports.

8 Jan 2010

Grubb & Ellis Healthcare REIT II to acquire the Center for Neurosurgery and Spine in Sartell

Grubb & Ellis Healthcare REIT II, Inc. today announced that it has entered into an agreement to acquire the Center for Neurosurgery and Spine, a 36,600-square-foot, two-building medical office portfolio in the St. Cloud suburb of Sartell. The acquisition is subject to customary closing conditions and the satisfaction of other requirements as detailed in the agreement.

8 Jan 2010

Health policy research roundup: Long-term care, diabetes disparities, health IT

Annals of Internal Medicine: Cultural Competency Training and Performance Reports to Improve Diabetes Care for Black Patients - In this study, researchers measure the effects cultural competency training and performance training for physicians has on the clinical outcomes for black patients with diabetes.

8 Jan 2010

Japanese MHLW approves Abbott's XIENCE V Everolimus Eluting Coronary Stent System

Abbott announced today that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved its XIENCE V® Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.

8 Jan 2010

Jamba Juice and CAHPERD join to introduce the 2010 Jamba Jump Day event

Jamba Juice Company and The California Association for Health, Physical Education, Recreation and Dance (CAHPERD) announced today its shared mission to keep California's children healthy and active with the 2010 Jamba Jump Day(TM) event -- a mass attempt to break the Guinness World Record for the "Most People Jumping/Skipping Rope at the Same Time".

8 Jan 2010

ESF-UB Conference to concentrate on potentially clinically relevant polymorphisms

Pharmacogenetics started in the fifties with the discovery of primaquine-related haemolysis among glucose-6-phosphate deshydrogenase deficient patients. At the end of the century, it progressively evolved into Pharmacogenomics, investigating simultaneously multiple gene targets till covering the whole genome in relation with altered drug response.

8 Jan 2010

Critically ill children with flu-like symptoms should be treated preemptively with antiviral medications

Lessons learned from the first 13 children at Johns Hopkins Children's Center to become critically ill from the H1N1 virus show that although all patients survived, serious complications developed quickly, unpredictably, with great variations from patient to patient and with serious need for vigilant monitoring and quick treatment adjustments.

8 Jan 2010

Scientists and clinicians address diagnosis and treatment for autoimmune and autoinflammatory diseases

Autoimmune and autoinflammatory diseases are a major health issue. The National Institutes of Health reports that up to 23.5 million Americans are afflicted. The American Autoimmune Related Diseases Association reports the number is closer to 50 million. Scientists and clinicians at The University of Texas Health Science Center at Houston can address the diagnosis and treatment of these conditions, as well as the latest advances in research.

8 Jan 2010

Chinese researchers become the world's fifth most prolific contributors to regenerative medicine

Chinese researchers have become the world's fifth most prolific contributors to peer-reviewed scientific literature on clock-reversing regenerative medicine even as a skeptical international research community condemns the practice of Chinese clinics administering unproven stem cell therapies to domestic and foreign patients.

8 Jan 2010

Amira Pharmaceuticals achieves another development milestone in its FLAP program

Amira Pharmaceuticals, Inc. announced today that it has achieved another development milestone in its FLAP program, which is partnered with GlaxoSmithKline. This milestone is related to the successful development of a solid dose formulation, which is critical for future development and commercialization activities.

8 Jan 2010

LAB Research completes research and development program that involves pulmonary monitoring system

LAB Research Inc. ("LAB" or "LAB Research"),a Canadian-based global non-clinical contract research organization, today announced that it recently completed a research and development program that involves real time quantitative pulmonary monitoring of non-human primates using wireless telemetry technology.

8 Jan 2010

Use of technology that expands access to qualified radiologist leads to earlier diagnosis and treatment of breast cancer

Use of technology that expands access to the most qualified radiologist will lead to earlier diagnosis and treatment of breast cancer, said MedSolutions, a leading provider of medical cost management services.

8 Jan 2010

Sinexus renamed as Intersect ENT; begins clinical study on new bioabsorbable stent

Sinexus has changed its name to Intersect ENT. Intersect's initial focus is a bioabsorbable drug eluting stent to treat patients with chronic sinusitis, a debilitating condition that affects 37 million people each year and is more prevalent than heart disease or asthma.

8 Jan 2010

Scientists identify gene underlying a disease that causes temporary paralysis of skeletal muscle

Scientists have identified a gene underlying a disease that causes temporary paralysis of skeletal muscle. The finding, they say, illustrates how investigations of rare genetic diseases can drive insights into more common ones.

8 Jan 2010

Heart Disease News and Research

Latest Heart Disease News and Research

LehmanMillet honored with four prestigious industry awards

Svelte Medical Systems initiates European clinical trial for SOAW delivery system

Boston Scientific's PROMUS Everolimus-Eluting Coronary Stent System receives Japanese marketing approval

FDA grants unconditional approval for World Heart's Levacor VAD BTT study

Health Canada clears Zargis Cardioscan device for sale in Canada

VA expected to move soon to cover more effects of Agent Orange

Possible loopholes, insurance costs in Senate health bill

Grubb & Ellis Healthcare REIT II to acquire the Center for Neurosurgery and Spine in Sartell

Health policy research roundup: Long-term care, diabetes disparities, health IT

Japanese MHLW approves Abbott's XIENCE V Everolimus Eluting Coronary Stent System

Jamba Juice and CAHPERD join to introduce the 2010 Jamba Jump Day event

ESF-UB Conference to concentrate on potentially clinically relevant polymorphisms

Critically ill children with flu-like symptoms should be treated preemptively with antiviral medications

Scientists and clinicians address diagnosis and treatment for autoimmune and autoinflammatory diseases

Chinese researchers become the world's fifth most prolific contributors to regenerative medicine

Amira Pharmaceuticals achieves another development milestone in its FLAP program

LAB Research completes research and development program that involves pulmonary monitoring system

Use of technology that expands access to qualified radiologist leads to earlier diagnosis and treatment of breast cancer

Sinexus renamed as Intersect ENT; begins clinical study on new bioabsorbable stent

Scientists identify gene underlying a disease that causes temporary paralysis of skeletal muscle

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in